ArticleSurgical case reports2026
Repair of Ventricular Septal Defect in Children with
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCASE PRESENTATION: Patient 1, a 7-month-old boy with Klinefelter syndrome and a TAB2 variant, presented with a VSD and extracardiac features. He developed severe congestive heart failure and pulmonary hypertension with impaired biventricular function. Despite medical management, his condition worsened, necessitating surgical patch closure. Postoperatively, he required intensive support, including nitric oxide and inotropes, for low cardiac output and persistent pulmonary hypertension. He was successfully extubated on day 7. Two years after surgery, the patient remains in New York Heart Association (NYHA) functional class I with improved biventricular function. Patient 2, a 1-year-4-month-old boy with a TAB2 gene deletion (6q24.3-q25.1), presented with a VSD, cardiomyopathy, and dysmorphic features. Due to decreased biventricular function, treatment with carvedilol and enalapril maleate was initiated at 3 months of age and his cardiac function gradually improved by 1 year of age. Although surgical patch closure of the VSD was performed, postoperative biventricular failure necessitated a 7-day course of extracorporeal membrane oxygenation. His recovery was further complicated by
conclusionsSuccessful VSD repair was achieved in 2 children with dilated ventricles and impaired cardiac function associated with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.